U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. Resources | Drugs
  4. Information for Consumers and Patients | Drugs
  5. Prescription Drug Advertising
  6. Center for Drug Evaluation and Research National Survey on Numerical Claims in Prescription Drug Advertising
  1. Prescription Drug Advertising

Center for Drug Evaluation and Research National Survey on Numerical Claims in Prescription Drug Advertising

OMB Control Number: 0910-0929
Expiration Date: 06/30/2027

The National Survey on Numerical Claims in Prescription Drug Advertising is designed to assess how adults interpret different claims used in prescription drug advertising. Findings from this study will help to improve claims that use numbers or “numerical” claims.

This FDA-sponsored survey uses an address-based sampling method to contact a nationally representative sample of U.S. adults. The survey is mailed to households from July to September, 2024 and adults (18 years and older) are asked to complete the web-based survey. Participation will help improve claims made about benefits and risks in prescription drug advertising.

Back to Top